More than half of risk-based accountable care organizations (ACOs) currently enrolled in the Medicare Shared Savings Program said they are likely to drop out due to the fear of paying losses resulting from the coronavirus disease 2019 (COVID-19) pandemic, according to a survey conducted by The National Association of Accountable Care Organizations.
More than half (56%) of risk-based accountable care organizations (ACOs) currently enrolled in the Medicare Shared Savings Program (MSSP) said they are likely to drop out of the program due to the fear of paying losses resulting from the coronavirus disease 2019 (COVID-19) pandemic, according to a survey conducted by The National Association of Accountable Care Organizations (NAACOS).
Of the 226 ACOs that completed the survey, nearly 60% reported they are likely to quit the program to avoid financial losses. In addition, 77% reported they are "very concerned" about COVID-19’s impact on their 2020 performance.
The MSSP program rewards ACOs for lowering spending and improving patient outcomes. It is the largest value-based payment model in Medicare, with an estimated savings of up to $3.53 billion between 2013 and 2017.
A separate NAACOS analysis found the COVID-19 pandemic could cost Medicare between $38.5 billion and $115.4 billion over the next year alone.
“When ACOs made a commitment to assume risk, they didn’t expect they’d be handling the risk of a global pandemic,” said Clif Gaus, president and CEO of NAACOS, in a press release.
Organizations are currently able to quit the program without penalty before May 31, 2020.
“Medicare’s decade-long effort to change how we pay for healthcare to better reward quality and outcomes may be lost unless Washington acts quickly to throw these providers a lifeline,” Gaus said.
Respondents completed the survey online from April 3-8. Specifically, when asked how likely an ACO would be to leave MSSP:
In March, NAACOS and other healthcare organizations asked CMS to “hold harmless” providers in alternative payment models from performance-related penalties for 2020.
“CMS has yet to adequately mitigate the costs and disruptions of the pandemic,” Gaus said, adding millions of Medicare beneficiaries would lose access to care coordination and quality improvement offered by ACOs should the organizations drop out of the program.
Disruptions in routine chronic care management, lack of in-office visits, rescheduling of elective procedures, and diversion of quality control staff to address the pandemic all contribute to ACOs’ concerns.
The survey also found 90% of ACOs report the COVID-19 pandemic will have a "significant" or "very significant" effect on their abilities to earn shared savings.
In addition, there is uncertainty on how the pandemic will affect “changes to acuity or risk scores, diminished opportunities to meet quality requirements related to preventive care, and which patients the ACO will be accountable for this year,” according to NAACOS.
As a result of the pandemic, 25% of respondents said they expect spending to increase by more than 10%, while 25% also responded they expect spending to increase between 5% and 10%. Of all the respondents, 37% selected "don’t know," which, according to NAACOS, illustrates the great uncertainty ACOs face.
“ACOs’ acceptance of financial risk did not account for a global pandemic," NAACOS concludes. "ACO providers are risking their lives treating COVID-19 patients. They should not also be required to risk their businesses, many of which are not equipped to potentially pay millions to the government for increased costs from COVID-19.”
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More